Gilles Delage

3.6k total citations
114 papers, 2.2k citations indexed

About

Gilles Delage is a scholar working on Epidemiology, Infectious Diseases and Management of Technology and Innovation. According to data from OpenAlex, Gilles Delage has authored 114 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Epidemiology, 31 papers in Infectious Diseases and 30 papers in Management of Technology and Innovation. Recurrent topics in Gilles Delage's work include Blood donation and transfusion practices (30 papers), Hepatitis B Virus Studies (15 papers) and Blood transfusion and management (14 papers). Gilles Delage is often cited by papers focused on Blood donation and transfusion practices (30 papers), Hepatitis B Virus Studies (15 papers) and Blood transfusion and management (14 papers). Gilles Delage collaborates with scholars based in Canada, United States and United Kingdom. Gilles Delage's co-authors include Marc Germain, Mindy Goldman, Sheila F. O’Brien, France Bernier, Pierre Robillard, L Lafleur, Bernard Willems, L Chicoine, Gaston Godin and François Proulx and has published in prestigious journals such as Blood, Gastroenterology and American Journal of Clinical Nutrition.

In The Last Decade

Gilles Delage

112 papers receiving 2.1k citations

Peers

Countries citing papers authored by Gilles Delage

Since Specialization

Citations

This map shows the geographic impact of Gilles Delage's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gilles Delage with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gilles Delage more than expected).

Fields of papers citing papers by Gilles Delage

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gilles Delage. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gilles Delage. The network helps show where Gilles Delage may publish in the future.

Co-authorship network of co-authors of Gilles Delage

This figure shows the co-authorship network connecting the top 25 collaborators of Gilles Delage. A scholar is included among the top collaborators of Gilles Delage based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gilles Delage. Gilles Delage is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Risk of variant Creutzfeldt–Jakob disease in a simulated cohort of Canadian blood donors 2023 ·Vox Sanguinis ·(unknown), Marc Germain, Sheila F. O’Brien, Gilles Delage, Christian Renaud, Antoine Lewin	0
2	Reported non‐compliance with pre‐donation screening among blood donors in Québec, Canada: A focus on the 3‐month deferral for men who have sex with men 2022 ·Vox Sanguinis ·Antoine Lewin, Yves Grégoire, Gilles Delage, (unknown), (unknown), (unknown), Éric Parent, Christian Renaud	4
3	Cost‐effectiveness of pathogen reduction technology for plasma and platelets in Québec: A focus on potential emerging pathogens 2022 ·Transfusion ·Yves Grégoire, Gilles Delage, Brian Custer, (unknown), Christian Renaud, Antoine Lewin, Marc Germain	6
4	Risk of transmission of severe acute respiratory syndrome coronavirus 2 by transfusion: A literature review 2020 ·Transfusion ·J LEBLANC, Marc Germain, Gilles Delage, Sheila F. O’Brien, Steven J. Drews, Antoine Lewin	30
5	Human T‐cell lymphotropic virus: A simulation model to estimate residual risk with universal leucoreduction and testing strategies in Canada 2018 ·Vox Sanguinis ·Sheila F. O’Brien, Qilong Yi, Mindy Goldman, Yves Grégoire, Gilles Delage	6
6	Factors associated with a second deferral among donors eligible for re‐entry after a false‐positive screening test for syphilis, HCV, HBV and HIV 2018 ·Vox Sanguinis ·Yves Grégoire, Marc Germain, Gilles Delage	6
7	The Epidemiology of Imported Malaria and Transfusion Policy in 5 Nonendemic Countries 2015 ·Transfusion Medicine Reviews ·Sheila F. O’Brien, Gilles Delage, Clive R. Seed, Josiane Pillonel, (unknown), Katy Davison, Alan D. Kitchen, Whitney R. Steele, David A. Leiby	44
8	Promoting the return of lapsed blood donors: A seven-arm randomized controlled trial of the question–behavior effect. 2013 ·Health Psychology ·Gaston Godin, Marc Germain, Mark Conner, Gilles Delage, Paschal Sheeran	40
9	Donation by donors with an atypical pulse rate does not increase the risk of cardiac ischaemic events 2012 ·Vox Sanguinis ·Marc Germain, Gilles Delage, Yves Grégoire, Pierre Robillard	5
10	Proceedings of a Consensus Conference: Risk-Based Decision Making for Blood Safety 2011 ·Transfusion Medicine Reviews ·(unknown), Morris A. Blajchman, Gilles Delage, Margaret Fearon, Dana V. Devine	20
11	Use of hemovigilance data to evaluate the effectiveness of diversion and bacterial detection 2011 ·Transfusion ·Pierre Robillard, Gilles Delage, (unknown), Mindy Goldman	32
12	Which survey questions change behavior? Randomized controlled trial of mere measurement interventions. 2010 ·Health Psychology ·Gaston Godin, Paschal Sheeran, Mark Conner, Gilles Delage, Marc Germain, Ariane Bélanger‐Gravel, Herminé Naccache	75
13	Proceedings of a consensus conference: the screening of blood donors for variant CJD1 1This Consensus Conference took place at the Ritz Carlton Hotel in Montreal, Quebec, on March 26–28, 2003, and was chaired by Dr. Gilles Delage of Héma Québec. 2004 ·Transfusion Medicine Reviews ·Morris A. Blajchman, Mindy Goldman, Kathryn E. Webert, Eleftherios C. Vamvakas, Judith Hannon, Gilles Delage	19
14	Prevention of posttransfusion CMV in the era of universal WBC reduction: a consensus statement 2001 ·Transfusion ·Andreas Laupacis, (unknown), (unknown), Gilles Delage, John Freedman, Heather Hume, Susan King, Steve Kleinman, Tony Mazzulli, George Wells	47
15	Risk factors for acquisition of hepatitis C virus infection in blood donors: Results of a case-control study 1999 ·Gastroenterology ·Gilles Delage, Claire Infante‐Rivard, Joanne Chiavetta, Bernard Willems, David Pi, (unknown)	83
16	Risk of HIV infection from blood transfusion in Montreal. 1997 ·PubMed ·Robert S. Remis, Gilles Delage, (unknown)	10
17	Immune Response to Verotoxin 1 and 2 in Children with Escherichia Coli O157:H7 Hemorrhagic Colitis and Classic Hemolytic Uremic Syndrome 1995 ·Canadian Journal of Infectious Diseases and Medical Microbiology ·François Proulx, Jean P. Turgeon, Gilles Delage, H. Lior, L Lafleur, L Chicoine	1
18	Immunization delivery methods: practice recommendations. 1994 ·PubMed ·(unknown), (unknown), Michał Abrahamowicz, Lucie Bédard, (unknown), (unknown), Gilles Delage, Michelle A. Miller, (unknown), (unknown)	9
19	Hepatitis a Vaccines: How will We Use Them? 1993 ·Canadian Journal of Infectious Diseases and Medical Microbiology ·Gilles Delage	1
20	Randomized, controlled trial of antibiotic therapy for Escherichia coli O157:H7 enteritis 1992 ·The Journal of Pediatrics ·François Proulx, Jean P. Turgeon, Gilles Delage, L Lafleur, L Chicoine	116

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact